The chemical class of ACCN5 Inhibitors comprises a diverse array of compounds that are conceptualized to modulate the activity of ACCN5, a member of the acid-sensing ion channel family. This class is characterized by its functional objective to influence ACCN5's role in detecting and responding to changes in extracellular pH, primarily in the context of neuronal signaling and sensory perception. The inhibitors in this class are not unified by a common chemical structure; instead, they are defined by their ability to target various aspects of ACCN5's function, either by directly affecting its ion-conducting properties or by modulating its sensitivity to pH changes. One of the primary approaches within this class is to target the ion channel activity of ACCN5. This strategy involves compounds that can block the ion-conducting pore of ACCN5, thereby inhibiting the flow of ions through the channel. This inhibition is crucial as it directly impacts ACCN5's primary function of converting extracellular pH changes into electrical signals within neurons. By blocking this ion flow, these inhibitors can alter ACCN5's role in sensory perception, particularly in pathways related to pain and mechanosensation. Another significant approach targets the pH sensitivity of ACCN5. These compounds are designed to modify ACCN5's response to extracellular pH changes, either by altering the channel's gating mechanism or by changing its pH sensitivity. This method of inhibition recognizes the nuanced role of ACCN5 in detecting and responding to acidosis in the neuronal environment. It aims to modulate ACCN5's activity in conditions where changes in pH are a critical factor, such as in ischemic conditions or inflammation.
The exploration of ACCN5 Inhibitors is significant in advancing our understanding of ion channel function, particularly in the context of acid sensing and neuronal signaling. By focusing on ACCN5, these inhibitors provide valuable insights into the mechanisms by which acid-sensing ion channels contribute to neuronal excitability and sensory perception. The development of these inhibitors is not just an exploration of ACCN5's functionality but also an investigation into the broader implications of modulating ion channel activity in physiological and possibly pathological states. The study of ACCN5 inhibitors highlights the importance of understanding ion channel dynamics, offering a window into how alterations in ion channel activity can impact cellular signaling and responses.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Amiloride can inhibit ASIC channels by blocking their ion-conducting pore and might inhibit ACCN5 in a similar manner. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
Ibuprofen, a nonsteroidal anti-inflammatory drug, could possibly inhibit ACCN5 by influencing acidosis-related conditions. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $50.00 $128.00 | ||
Lidocaine, known for its local anesthetic effects, might inhibit ACCN5's role in pain pathways. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc ions can modulate the activity of various ion channels, including ASICs, and might inhibit ACCN5. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $145.00 $450.00 | 11 | |
Capsazepine, though a TRPV1 antagonist, could inhibit ACCN5 due to potential off-target effects on ASIC channels. | ||||||